LDV Capital

We are thrilled to invite you to our 11th Annual LDV Vision Summit – a free virtual event on March 25, 2025! Since its inception in 2014, the summit has been the premier global gathering in #VisualTech and #AI. Over 15 fantastic speakers ranging from tech giants to under-the-radar startups, esteemed research labs and leading venture capital firms will be sharing their insights on state-of-the-art computer vision, machine learning, and AI solutions aimed at improving the world we live in. Meet the first two: - Luciana Lixandru is a Partner at Sequoia Capital, co-leading early-stage investments with Alfred Lin. She focuses on European enterprise and consumer tech. Luciana identified the trend in RPA ahead of the venture industry and led the Series A in UiPath. Luciana has also been a valuable business partner to Deliveroo, Miro, Tessian and many others. - Jan Kautz leads NVIDIA’s Learning & Perception Research Team, working on computer vision problems — from low-level vision and geometric vision to visual perception, as well as machine learning problems. Their goal is to accelerate humanoid #robotics development. RSVP to attend👇

Evan Nisselson first met Roelof Botha, Managing Partner and Steward of Sequoia Capital, while fundraising for his startup in 2005. Roelof said, ”I think back to that meeting we had, and you had a vision for the future and the impact of visual, just imagery on consumer experiences was completely spot on." At our 10th Annual LDV Vision Summit, Roelof joined Evan for a fireside chat to discuss trends and early-stage investment opportunities in businesses leveraging visual technologies and #AI. They spoke about Roelof’s insights from the ups and downs of the PayPal days, marshmallow tests, personality traits and much more! If you missed our Summit, this is your chance to watch the video or read our lightly edited transcript 👇

Congratulations to Rob Baldoni, Co-Founder and CEO of DANNCE.ai—one of the newest additions to our LDV portfolio—on being named to the 2025 Forbes 30 Under 30 #Healthcare list! Rob and his brilliant team are bringing to market a phenotyping platform that digitizes the clinical assessments used by clinicians and drug developers to quantify movement. The company offers a novel approach to the clinical exam by processing patient videos and automatically analyzing them for signs of neurological disease. The platform also evaluates treatment efficacy, all with the goal of enhancing drug effectiveness and improving the lives of people with movement disorders. #Neuroscience #AI #deeptech

Many of us know someone affected by Parkinson's or another movement disorder, and we’ve seen the challenges they face. Treatment for these conditions varies widely, depending not only on the specific diagnosis but also on how accurately symptoms are measured and monitored over time. Precise tracking of symptoms is essential to tailoring treatments effectively, helping doctors and patients better understand disease progression and response to therapies. We at LDV Capital are thrilled to partner with the brilliant #deeptech team at DANNCE.ai to leverage advanced computer vision solutions to increase drug efficacy and significantly improve the lives of people with movement disorders. We led their $2.6M pre-seed round along with co-investors Glasswing Ventures, Leo Lion Limited Company, Duke Capital Partners and Merck Digital Sciences Studio. We thrive on investing in people building innovative solutions that enhance people’s lives and provide substantial value. See more details in Evan Nisselson’s article👇

Our portfolio company Ezra is the healthcare #AI startup revolutionizing early cancer detection through full-body MRI screening. Ezra announced the most advanced longevity scan in partnership with Bryan Johnson, the world's most measured human. It offers detailed insights into your body’s composition, brain age, coronary health and much more. With our promo code "LDV", you’ll receive $150 off standard scans and $300 off Blueprint -> https://ezra.com/

Congratulations to LDV Community member Paul Nemirovsky and the dMetrics team on their amazing achievements! Their platform enables DoD analysts to create custom ML agents that scan large datasets, identifying key entities, actions, and relationships—cutting analysis time by 90%. DTIC awarded dMetrics a five-year, $99.5M contract to support the government’s efforts to make faster, data-driven decisions. This contract ensures ongoing support for DoD analysts in identifying adversarial online activity rapidly and at scale.

You’re likely aware of the surge in weight-loss drugs and may have heard about the new wave of anti-cancer drugs. But how familiar are you with #radioisotope or small molecule therapies? And what do these advances mean for all of us? Are you excited about the shift toward personalized medicine and treatments tailored to patients’ genetic profiles? Dr. David R.—a serial #biotech entrepreneur, investor, and one of our LDV Capital Experts in life sciences and biotech—shares his insights on investment trends. This article not only offers an overview of the industry’s latest innovations but also provides a glimpse into this year’s LDV Capital Annual General Meeting, an exclusive invite-only event for our LPs, portfolio companies, LDV experts, and special guests. 👇

🌟 Big News from Glass Imaging! 🌟 We’re excited to announce that GlassAI technology is now available on Qualcomm’s Snapdragon 8 Elite platform! 🚀 Unveiled at the Snapdragon Summit 2024, GlassAI brings cutting-edge AI-driven imaging capabilities to the Snapdragon ecosystem, pushing the boundaries of mobile photography. With this integration, we’re enabling superior image quality, precision, and performance for mobile devices, making high-end camera functionality more accessible than ever before. Thank you to the Glass Imaging team for making this possible, and to Qualcomm for their support and partnership. Read more: https://lnkd.in/gQvk2V-7 #SnapdragonSummit2024 #GlassAI #SnapdragonElite #MobileImaging #Innovation #AI #Qualcomm

Amazing significant breakthrough for Sonus Microsystems, a LDV Capital portfolio company – they successfully developed and tested a phased-array transducer for cardiac imaging. This is the first-ever polymer transducer for heart imaging, and they can now capture real-time cardiac images! According to a cardiac sonographer who reviewed our prototype, the images produced are of clinical quality and superior to the PZT transducer connected to the same backend.

We at LDV Capital love investing in brilliant people pre-revenue at the prototype stage, building #deeptech solutions to solve huge problems, hopefully improve our world and create a lot of value.